Diabetes and Erectile Dysfunction: Why Blood Retention Is Usually the Problem

Diabetes is the single strongest medical association with erectile dysfunction, and the reason matters. In diabetes the problem is frequently not that too little blood arrives, but that the tissue cannot hold it. That distinction explains a pattern many diabetic men recognize: medication produces something, but not enough, and not for long.

How common erectile dysfunction is in diabetes

A systematic review and meta-analysis of 145 studies covering 88,577 men found an overall erectile dysfunction prevalence of 52.5% among men with diabetes. Broken down by type, prevalence was 37.5% in Type 1 diabetes and 66.3% in Type 2.

Compared with men without diabetes, the odds of erectile dysfunction were more than three and a half times higher (odds ratio 3.62).

Erectile difficulty also tends to appear earlier in diabetic men than in the general population, and to become more common the longer the condition has been present.

Why diabetes affects erections

Several mechanisms operate at once, which is part of why diabetic erectile dysfunction is harder to treat than most.

Smooth muscle that cannot relax properly

An erection requires the smooth muscle inside the erectile chambers to relax so the tissue can fill and expand. Research at Boston University School of Medicine found that erectile tissue taken from diabetic men shows impaired ability to relax that smooth muscle.

This matters more than it might sound. Full expansion of the erectile tissue is what compresses the veins against the surrounding sheath and traps blood inside. If the tissue cannot expand fully, the veins are never properly compressed, and blood continues to escape. The result is veno-occlusive dysfunction — venous leak — arising from a tissue problem rather than a vein problem.

Nerve damage

Diabetic neuropathy affects the autonomic nerves that trigger and sustain the erectile response. Signaling that should initiate smooth muscle relaxation is weakened, which compounds the tissue problem above.

Endothelial dysfunction

The endothelium is the lining of blood vessels, and it releases nitric oxide, the signaling molecule at the center of the erectile response. Sustained high blood glucose damages endothelial function throughout the body. Because the penile arteries are narrow, the effect is often noticeable there before it is noticeable elsewhere.

Associated conditions

Men with Type 2 diabetes frequently also have hypertension, raised lipids, obesity, or low testosterone, each of which independently affects erectile function. Some medications used to manage these conditions have their own effect — covered in our article on medications that affect erections.

Why oral medication often disappoints in diabetes

PDE5 inhibitors work by amplifying a nitric oxide signal that is already present. They increase blood flow into the penis. They do not make erectile tissue expand more completely, and they do not restore the veno-occlusive seal.

For a man whose difficulty is chiefly that blood arrives but does not stay, more inflow produces a partial result. The erection may start and then fade, or feel soft despite adequate arousal. This is not a sign the medication was taken incorrectly, and it is not necessarily a reason to increase the dose indefinitely.

Before concluding that medication has failed, it is worth confirming the trial was a fair one. The 2018 AUA Erectile Dysfunction Guideline carries two Strong Recommendations on this point: that men should be given proper instruction on use, and that the dose should be titrated for optimal effect. Many apparent failures are inadequate trials.

What tends to help

Glycemic control

Better long-term glucose control slows the vascular and neurological damage that drives the problem. It works slowly and it does not reverse established damage, but it protects what remains. It is the only measure on this list that addresses the underlying cause.

Addressing the outflow side

Where the dominant problem is retention rather than filling, approaches that improve blood retention address the actual mechanism. These can be used alone or alongside a medication that supports inflow. Combination approaches are explicitly permitted under the guideline's shared decision-making framework, which we cover in this article.

Injections

Intracavernosal injections act directly on the erectile tissue rather than depending on nerve signaling, which is why they often work in diabetic men when tablets do not. The guideline requires an in-office test dose before self-administration.

Cardiovascular assessment

Erectile dysfunction in a diabetic man is a vascular finding. The 2018 AUA Guideline states as a Clinical Principle that men should be counseled that erectile dysfunction is a risk marker for underlying cardiovascular disease warranting evaluation. In diabetes, where cardiovascular risk is already elevated, that principle carries more weight rather than less.

What to raise with your doctor

• Describe the pattern, not just the problem. Whether you can achieve an erection but not keep it, whether it fades on changing position, and whether morning erections continue. These point toward different mechanisms.
• Ask whether the problem is inflow, outflow, or both. "Vascular" on its own does not tell you which.
• Confirm you have had a fair trial of any medication — correct instructions and a properly titrated dose — before concluding it does not work for you.
• Ask about approaches that address retention if the pattern suggests blood is not staying.
• Ask for cardiovascular risk assessment, which is warranted on the erectile finding alone.
• Ask about testosterone. The guideline recommends measuring morning total testosterone in men with erectile dysfunction, and low testosterone is more common in Type 2 diabetes.

Diabetic erectile dysfunction has a reputation for being difficult, and that reputation is deserved. But a good deal of the difficulty comes from treating it as a blood flow problem when the dominant failure is in retention. Naming the mechanism correctly is what makes the conversation with a clinician productive.

References

• Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabetic Medicine. 2017;34(9):1185–1192. https://onlinelibrary.wiley.com/doi/10.1111/dme.13403
• Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. Journal of Urology. 2018;200(3):633–641. AUA Guidelines page
• Boston University School of Medicine research on erectile tissue from diabetic men and impaired smooth-muscle relaxation leading to loss of blood from the erection chambers.